A Study of Acute Myocardial Infarction Using FDY-5301
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT03470441
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose other
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Faraday Pharmaceuticals, Inc.
- Registry
-
NCT03470441
-
- Other papers using this trial's data
- A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Hungary, Poland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT03470441. Randomized; triple masking; primary purpose other. Start 2017-10-27 (actual); primary completion 2018-07-14 (actual). Results posted on 2021-12-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Acute Myocardial Infarction Using FDY-5301
- Condition
- Acute Myocardial Infarction
- Condition
- STEMI
- Intervention (Drug)
- FDY-5301
- Intervention (Other)
- Placebo
- Lead sponsor
- Faraday Pharmaceuticals, Inc.
Record details
- Record id
cardio:ct-nct03470441- Content hash
c385c133391503b60d1cbb3d6e10c8ea7f57f8eeebaa64a8166403e29b318b64